Skip to main content

If you remember nothing else from this blog post, remember this: sellers that peddle cures must have scientific proof to back up their claims. The FTC takes action when they don’t.

Case in point: The FTC alleges that Quantum Wellness Botanical Institute, LLC, its CEO, Fred Auzene, and former marketer, Maria Gutierrez Veloso, deceptively advertised ReJuvenation, as an anti-aging wonder pill. Ads promised that ReJuvenation would reverse the aging process, repair damage to the body, and treat diseases by stimulating the production of human growth hormone (HGH) and stem cells. The defendants boldly claimed that ReJuvenation could reverse or repair heart attack damage, heart disease, blindness, brain damage from stroke, Alzheimer’s disease, Parkinson’s disease, deafness, Crohn’s disease, and age-related damage to the body’s organs, tissues, and joints.

According to the FTC, the defendants worked hard to convince people to buy ReJuvenation, which cost between $39.95 and $49.95, plus shipping and handling, for a one-month supply.

In a proposed settlement announced today, the FTC says these claims were false or misleading, and the sellers had no reliable scientific evidence to back them up.

The proposed federal court orders would require the defendants to have human clinical testing to support future claims related to the treatment of any disease or health condition. The judgments total $3.4 million, which represents what people paid for ReJuvenation. After the defendants turn over $660,000, that money will be returned to ReJuvenation customers. The remainder of the judgment will be suspended due to inability to pay.

Be skeptical about ads promising miraculous results, or cures for lots of medical issues. Before you buy – or take – such a product, talk to a healthcare provider to make sure it’s right for you.

Check out ftc.gov/dietarysupplement for more information, and report any suspicious claims to the FTC.

 

It is your choice whether to submit a comment. If you do, you must create a user name, or we will not post your comment. The Federal Trade Commission Act authorizes this information collection for purposes of managing online comments. Comments and user names are part of the Federal Trade Commission’s (FTC) public records system, and user names also are part of the FTC’s computer user records system. We may routinely use these records as described in the FTC’s Privacy Act system notices. For more information on how the FTC handles information that we collect, please read our privacy policy.

The purpose of this blog and its comments section is to inform readers about Federal Trade Commission activity, and share information to help them avoid, report, and recover from fraud, scams, and bad business practices. Your thoughts, ideas, and concerns are welcome, and we encourage comments. But keep in mind, this is a moderated blog. We review all comments before they are posted, and we won’t post comments that don’t comply with our commenting policy. We expect commenters to treat each other and the blog writers with respect.

  • We won’t post off-topic comments, repeated identical comments, or comments that include sales pitches or promotions.
  • We won’t post comments that include vulgar messages, personal attacks by name, or offensive terms that target specific people or groups.
  • We won’t post threats, defamatory statements, or suggestions or encouragement of illegal activity.
  • We won’t post comments that include personal information, like Social Security numbers, account numbers, home addresses, and email addresses. To file a detailed report about a scam, go to ReportFraud.ftc.gov.

We don't edit comments to remove objectionable content, so please ensure that your comment contains none of the above. The comments posted on this blog become part of the public domain. To protect your privacy and the privacy of other people, please do not include personal information. Opinions in comments that appear in this blog belong to the individuals who expressed them. They do not belong to or represent views of the Federal Trade Commission.

lisa
February 05, 2020
It would be nice to know exactly where these comments actually go. It is not possible to inquire with anyone after posting a comment to find out. There is no comment number, no designator as to who or what is complying any comment entry. Who owns the subcontracted software platform that these comments are being directed to, and surveilled by who, what, and where, as it is not possible to find any comment, after submission anywhere on the FTC publicly accessible site portals.
FTC Staff
February 07, 2020

In reply to by lisa

The FTC's Privacy Act Statement and Blog Comment Policy are posted directly above the box where you typed your comment. 

The FTC's Privacy Act Statement explains how the FTC treats comments and user names. The Blog Comment Policy explains how we moderate the blog and other issues.

Don't use your…
February 07, 2020
They took in3.4 million and paid back 600 thousand???? Why? Where is the rest of the money?
FTC Staff
February 07, 2020

In reply to by Don't use your…

Follow the link in the blog to read the press release. The court order against Veloso for $2.4 million will be partially suspended after payment of $600,000.